0 NASDAQ Companies - November 11, 2024Invizyne Technologies Announces Pricing of $15 Million Initial Public OfferingMonrovia, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to […]Read More
0 NASDAQ Companies - November 11, 2024Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]Read More
0 NASDAQ Companies - November 11, 2024DoubleDown Interactive Reports Third Quarter 2024 Financial ResultsSEOUL, South Korea, Nov. 11, 2024 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a […]Read More
0 NASDAQ Companies - November 11, 2024Robinhood Markets, Inc. Reports October 2024 Operating DataMENLO PARK, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating […]Read More
0 NASDAQ Companies - November 11, 2024Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2024NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) — At the end of the settlement date of October 31, 2024, short […]Read More
0 NASDAQ Companies - November 11, 2024Bridger Aerospace Announces Record Third Quarter 2024 Results; Raises Revenue Guidance and Narrows Adjusted EBITDA EstimatesBELGRADE, Mont., Nov. 11, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: […]Read More
0 NASDAQ Companies - November 11, 2024Regeneron Announces Investor Conference PresentationsTARRYTOWN, N.Y., Nov. 11, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: • Jefferies […]Read More
0 NASDAQ Companies - November 11, 2024Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate UpdateRevenues increased 17% compared to the previous quarter ended June 30, 2024 Strengthened balance sheet is expected to provide sufficient […]Read More
0 NASDAQ Companies - November 11, 2024Artiva Biotherapeutics to Participate in the Jefferies London Healthcare ConferenceSAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is […]Read More
0 NASDAQ Companies - November 11, 2024CSX Executive Vice President and Chief Commercial Officer to Address Stephens Annual Investment ConferenceJACKSONVILLE, Fla., Nov. 11, 2024 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Commercial Officer, Kevin […]Read More